TOPページ
|
英語
日本語
|
CONNECT WITH US:
ホーム
JCNについて
サービス
お問い合わせ
会員企業ログイン
*
ホーム
プレスリリース
2023年07月31日 21時00分
Source:
China Medical System Holdings Ltd.
China Medical System Once Again Received MSCI-ESG 'AA' Rating, Leading the Industry in ESG Management
SHENZHEN, CHINA, 2023年07月31日 - (JCN Newswire) - Recently, MSCI (Morgan Stanley Capital International), the world's largest index company, announced the latest Environmental, Social, and Governance (ESG) evaluation report for China Medical System Holdings limited ("CMS" or the "Group"), who achieved an "AA" rating and surpassed 75% of global peers with leading ESG management practices.
MSCI is one of the most widely used, influential, and referenced rating companies in the global market. Based on a scientifically rigorous evaluation system, it evaluates companies' risk control performance and sustainable development potential comprehensively from various aspects such as environment, human capital, health accessibility, product safety and quality, and corporate governance. MSCI-ESG rating results have been regarded by global investors as an important non-financial basis for investment decision-making. Being back to the "AA" rating, reflects the full recognition of the Group's ESG management practices by the international authoritative rating company.
The Group deeply integrates the concept of sustainable development into its operations with a development perspective, continuously improves its internal governance under the guidance of its ESG strategy, and actively assumes its responsibilities as a corporate citizen. Based on years of continuous investment in sustainable development, CMS's ESG management has been widely recognized: over the past three years, the Group's MSCI-ESG rating has maintained an "A" or "AA; its S&P Global ESG score surpassed 92% of the global peers with a score of 53, and successfully stood out from approximately 1,600 Chinese companies to be included in the first "Sustainability Yearbook (China)" of S&P Global.
In the future, CMS will always keep in mind its mission of being a responsible citizen, and work together with its stakeholders to promote healthy, harmonious, and sustainable development of the industry, society, and environment.
About CMS:
CMS (0867.HK) is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet healthcare needs.
CMS focuses on developing first- or best-in-class innovative products and has made the layout of 30 differentiated pipeline products with strong market potential. CMS deeply engages in specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to strengthen the competitiveness of its cardio-cerebrovascular/gastroenterology business, and independently operated dermatology and medical aesthetic business, and ophthalmology business, whilst enhancing the scale and efficiency. CMS also entered into the Southeast Asian market to create new opportunities to further enhance the sustainable development of the Group.
Media Contact
Brand: China Medical System Holdings Ltd.
Contact: CMS Investor Relations
Email:
ir@cms.net.cn
Website:
https://web.cms.net.cn/en/home/
Source: China Medical System Holdings Ltd.
Source: China Medical System Holdings Ltd.
セクター: ヘルスケア, メドテック
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
関連プレスリリース
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025
2025年02月14日 21時00分
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10
2025年01月24日 23時00分
China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type
2025年01月09日 09時00分
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China
2024年12月09日 14時00分
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia
2024年12月02日 22時30分
China Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China
2024年09月24日 22時00分
China Medical System (00867) Released its 2024 Interim Results: Steady Increase in Revenue and Profit Compared with 2H 2023
2024年08月16日 14時00分
China Medical System: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in China
2024年08月05日 23時00分
China Medical System (867.HK) Reincluded in S&P Global Sustainability Yearbook (China Edition) and Maintained MSCI ESG "AA" Rating
2024年07月16日 21時00分
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China
2024年06月25日 21時46分
もっと見る >>
新着プレスリリース
Global Crypto Leaders to Converge in Dubai for Historic 30th Edition of HODL
2025年05月10日 01時15分
Solar & Storage Live Philippines 2025 Powers Up to Drive the Nation's Clean Energy Future
2025年05月09日 23時58分
ZA Miner Expands Cloud Mining Platform with Clean Energy Infrastructure and Increased Global Adoption
2025年05月09日 21時00分
Valuufy Selected by Global Tech Leader for Environmental Impact Assessment
2025年05月09日 18時00分
Valuufy、グローバルテックリーダーから環境影響評価業務を受託
2025年05月09日 17時00分
TOYOTA、2025年3月期 決算発表
2025年05月08日 14時00分
New Godzilla the Ride Film to Be Directed by Academy Award-Winning Takashi Yamazaki
2025年05月08日 11時00分
Honda、V型8気筒300馬力エンジン搭載の新型大型船外機「BF300」を発売
2025年05月07日 13時30分
富士通のソリューションを採用したソニー銀行様の新勘定系システムが稼働開始
2025年05月07日 13時30分
現実世界での探検を通じ、人々をつなぐ―Jagat宝探しイベント、日本初上陸
2025年05月02日 15時00分
Open Dialogue 'Future of the World. New Platform for Global Growth' Launches at Russia National Centre
2025年04月29日 16時00分
オープンダイアログ「世界の未来。グローバル成長の新たなプラットフォーム」がロシア国立センターで開催
2025年04月29日 14時00分
富士通、光ネットワークの発展に貢献したデジタルコヒーレント光受信技術により、令和7年春の褒章において紫綬褒章を受章
2025年04月28日 11時00分
米国株式アクティブ残高9年連続世界No.1ティー・ロウ・プライス[1] R&Iファンド大賞2025最優秀ファンド賞を受賞
2025年04月25日 15時15分
Honda、2025年3月度 四輪車 生産・販売・輸出実績を発表
2025年04月24日 15時15分
トヨタ、米国ウェストバージニア工場に8,800万ドルを追加投資
2025年04月24日 14時30分
トヨタ、2024年度 販売・生産・輸出実績を発表
2025年04月24日 13時35分
アリックスパートナーズ、中国自動車市場の最新調査を発表
2025年04月23日 13時00分
New Trading Bot Pivozon Targets Gold Traders Using Hourly Chart Strategies
2025年04月22日 16時00分
Meerkat ($MERK) introduces utility-focused meme ecosystem with staking, gaming, and AI features
2025年04月22日 12時00分
もっと見る >>